Recorded on October 4, 2019.
Rachel Haurwitz is the founder of Caribou Biosciences, a startup on the cutting edge of gene editing technologies — including animal and human DNA. She will chat with us about the ethical and scientific questions surrounding CRISPRing human embryos and what that could mean for the future of humanity.
The Ethics of Snipping DNA with CRISPR with Rachel Haurwitz (Caribou Biosciences)
From the collection TechCrunch Disrupt
May 27
Athens, Greece
StrictlyVC Athens is up next. Hear unfiltered insights straight from Europe’s tech leaders and connect with the people shaping what’s ahead. Lock in your spot before it’s gone.
